Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
150 participants
INTERVENTIONAL
2012-10-31
2015-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pain Associated With Endometriosis
NCT00758953
Study to Determine Intraperitoneal,Tissue, Serum Concentrations of VML-0501 Following Five Days of Daily Vaginal Single Dose of VML-0501 (100 mg Danazol), in Comparison to Oral Danazol Capsules Daily 600 mg), in Women With Signs and Symptoms of Endometriosis Undergoing Laparoscopy
NCT03352076
Endometriosis Impact on Oocyte Quality
NCT03241329
Perinatal Consequences of Endometriosis
NCT02498691
Pilot Study of the IL-1 Antagonist Anakinra for the Treatment of Endometriosis Related Symptoms
NCT03991520
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
control
patients treated with placebo for at least 4 months before IVF attempt
placebo
administered daily like the active comparator
danazol
patients treated with danazol (100mg/day)for at least 4 months before IVF attempt
Danazol
100 mg day for 4 monthh in women with diagnosed endometriosis before IVF
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Danazol
100 mg day for 4 monthh in women with diagnosed endometriosis before IVF
placebo
administered daily like the active comparator
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre for Endocrinology and Reproductive Medicine, Italy
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Fabio Scarpellini
Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marco Sbracia, MD
Role: STUDY_CHAIR
Centre for Endocrinology and Reproductive Medicine, Italy
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CERM
Rome, , Italy
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CR-09-2013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.